United-Guardian PE Ratio 2010-2024 | UG
Current and historical p/e ratio for United-Guardian (UG) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. United-Guardian PE ratio as of May 08, 2025 is 11.24.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| United-Guardian PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-05-08 | 8.03 | 11.31 | |
| 2024-12-31 | 9.26 | $0.71 | 13.04 |
| 2024-09-30 | 15.38 | $0.76 | 20.24 |
| 2024-06-30 | 8.42 | $0.71 | 11.86 |
| 2024-03-31 | 7.20 | $0.60 | 12.01 |
| 2023-12-31 | 6.59 | $0.56 | 11.77 |
| 2023-09-30 | 6.89 | $0.55 | 12.53 |
| 2023-06-30 | 7.47 | $0.48 | 15.57 |
| 2023-03-31 | 8.50 | $0.52 | 16.35 |
| 2022-12-31 | 9.44 | $0.56 | 16.86 |
| 2022-09-30 | 10.01 | $0.65 | 15.39 |
| 2022-06-30 | 13.20 | $0.80 | 16.51 |
| 2022-03-31 | 19.61 | $0.95 | 20.64 |
| 2021-12-31 | 14.19 | $1.01 | 14.04 |
| 2021-09-30 | 11.78 | $0.90 | 13.09 |
| 2021-06-30 | 12.45 | $0.84 | 14.82 |
| 2021-03-31 | 12.23 | $0.81 | 15.10 |
| 2020-12-31 | 11.60 | $0.72 | 16.12 |
| 2020-09-30 | 11.95 | $0.90 | 13.27 |
| 2020-06-30 | 11.67 | $0.97 | 12.03 |
| 2020-03-31 | 11.13 | $0.94 | 11.84 |
| 2019-12-31 | 15.13 | $1.04 | 14.55 |
| 2019-09-30 | 14.21 | $0.86 | 16.52 |
| 2019-06-30 | 14.08 | $0.92 | 15.31 |
| 2019-03-31 | 13.96 | $0.99 | 14.10 |
| 2018-12-31 | 13.37 | $0.95 | 14.07 |
| 2018-09-30 | 11.40 | $1.04 | 10.96 |
| 2018-06-30 | 13.52 | $0.99 | 13.66 |
| 2018-03-31 | 12.23 | $0.93 | 13.15 |
| 2017-12-31 | 12.73 | $0.84 | 15.15 |
| 2017-09-30 | 12.77 | $0.78 | 16.37 |
| 2017-06-30 | 10.12 | $0.74 | 13.67 |
| 2017-03-31 | 9.49 | $0.59 | 16.09 |
| 2016-12-31 | 9.91 | $0.56 | 17.69 |
| 2016-09-30 | 9.15 | $0.49 | 18.68 |
| 2016-06-30 | 10.03 | $0.55 | 18.23 |
| 2016-03-31 | 12.64 | $0.79 | 16.00 |
| 2015-12-31 | 11.71 | $1.00 | 11.71 |
| 2015-09-30 | 10.73 | $1.22 | 8.79 |
| 2015-06-30 | 11.37 | $1.05 | 10.83 |
| 2015-03-31 | 10.86 | $0.92 | 11.80 |
| 2014-12-31 | 11.55 | $0.89 | 12.97 |
| 2014-09-30 | 12.80 | $0.95 | 13.47 |
| 2014-06-30 | 16.39 | $1.14 | 14.38 |
| 2014-03-31 | 16.52 | $1.23 | 13.43 |
| 2013-12-31 | 15.91 | $1.28 | 12.43 |
| 2013-09-30 | 13.88 | $1.19 | 11.66 |
| 2013-06-30 | 13.52 | $1.15 | 11.76 |
| 2013-03-31 | 10.56 | $1.12 | 9.43 |
| 2012-12-31 | 10.70 | $1.05 | 10.19 |
| 2012-09-30 | 9.78 | $0.98 | 9.98 |
| 2012-06-30 | 9.59 | $1.04 | 9.22 |
| 2012-03-31 | 9.32 | $1.05 | 8.87 |
| 2011-12-31 | 7.74 | $1.03 | 7.52 |
| 2011-09-30 | 7.36 | $1.00 | 7.36 |
| 2011-06-30 | 7.19 | $0.97 | 7.42 |
| 2011-03-31 | 7.27 | $0.83 | 8.76 |
| 2010-12-31 | 6.74 | $0.80 | 8.43 |
| 2010-09-30 | 6.71 | $0.80 | 8.39 |
| 2010-06-30 | 5.57 | $0.75 | 7.42 |
| 2010-03-31 | 5.83 | $0.77 | 7.57 |
| 2009-12-31 | 5.27 | $0.78 | 6.75 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.037B | $0.012B |
| UNITED GUARDIAN conducts research, product development, manufacturing and marketing of pharmaceuticals, cosmetics, health care products, medical devices, and proprietary industrial products. They also distributes a line of over 3,000 fine organic chemicals, research chemicals, test solutions, indicators, dyes and reagents. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.051B | 28.02 |
| Boston Scientific (BSX) | United States | $155.046B | 38.81 |
| Stryker (SYK) | United States | $146.591B | 30.65 |
| EssilorLuxottica (ESLOY) | France | $128.427B | 0.00 |
| Medtronic (MDT) | Ireland | $106.656B | 15.57 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.804B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.530B | 27.59 |
| ResMed (RMD) | United States | $35.880B | 26.95 |
| GE HealthCare Technologies (GEHC) | United States | $31.512B | 14.96 |
| Agilent Technologies (A) | United States | $30.654B | 20.25 |
| Terumo (TRUMY) | Japan | $28.279B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.455B | 16.14 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.623B | 11.96 |
| Insulet (PODD) | United States | $18.597B | 79.37 |
| Baxter (BAX) | United States | $15.765B | 11.77 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.408B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.910B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.514B | 22.02 |
| Lantheus Holdings (LNTH) | United States | $5.512B | 14.05 |
| Prestige Consumer Healthcare (PBH) | United States | $4.033B | 19.25 |
| Perrigo (PRGO) | Ireland | $3.604B | 9.20 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.310B | 28.20 |
| Haemonetics (HAE) | United States | $3.228B | 15.19 |
| Envista Holdings (NVST) | United States | $2.854B | 23.72 |
| GN Store Nord (GNNDY) | Denmark | $2.010B | 16.65 |
| LeMaitre Vascular (LMAT) | United States | $1.844B | 41.21 |
| QuidelOrtho (QDEL) | United States | $1.744B | 12.02 |
| AtriCure (ATRC) | United States | $1.500B | 0.00 |
| Neogen (NEOG) | United States | $1.287B | 16.47 |
| Green Thumb Industries (GTBIF) | United States | $1.274B | 28.67 |
| Kestra Medical Technologies (KMTS) | United States | $1.121B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.111B | 11.28 |
| BioLife Solutions (BLFS) | United States | $1.014B | 0.00 |
| InMode (INMD) | Israel | $0.989B | 9.06 |
| Phibro Animal Health (PAHC) | United States | $0.785B | 10.05 |
| Evolus (EOLS) | United States | $0.758B | 0.00 |
| Owens & Minor (OMI) | United States | $0.599B | 5.11 |
| CeriBell (CBLL) | United States | $0.577B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.565B | 0.00 |
| Valneva SE (VALN) | France | $0.551B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.539B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.435B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.411B | 0.00 |
| Surmodics (SRDX) | United States | $0.388B | 0.00 |
| Omeros (OMER) | United States | $0.370B | 0.00 |
| SNDL (SNDL) | Canada | $0.342B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.337B | 14.59 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.315B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.287B | 24.23 |
| Verano Holdings (VRNOF) | United States | $0.287B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.283B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.270B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.258B | 45.90 |
| Cerus (CERS) | United States | $0.249B | 0.00 |
| ZimVie (ZIMV) | United States | $0.248B | 14.83 |
| Canopy Growth (CGC) | Canada | $0.237B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.216B | 0.00 |
| Quanterix (QTRX) | United States | $0.208B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Biote (BTMD) | United States | $0.183B | 5.14 |
| Utah Medical Products (UTMD) | United States | $0.177B | 14.27 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| Brainsway (BWAY) | Israel | $0.164B | 51.24 |
| Organigram Global (OGI) | Canada | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.149B | 18.39 |
| Jin Medical (ZJYL) | China | $0.126B | 0.00 |
| Exagen (XGN) | United States | $0.123B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.116B | 0.00 |
| MacroGenics (MGNX) | United States | $0.094B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Agape ATP (ATPC) | $0.086B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.70 |
| Veru (VERU) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Zynex (ZYXI) | United States | $0.063B | 0.00 |
| United Health Products (UEEC) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| Apyx Medical (APYX) | United States | $0.047B | 0.00 |
| ImmuCell (ICCC) | United States | $0.047B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 56.00 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |